一个由专家主导的ECMO认证途径和前4年的安全数据
Stuart C Duffin1, Judith H Askew1, Timothy J Southwood1
1Royal Prince Alfred Hospital, Sydney, Australia.
概括
一个由强化治疗师领导的体外膜氧化 (ECMO) 计划在四年内实现了98.5%的管成功率,并发症率为7.96%. 这证明了复杂的ECMO治疗的有效培训和技术.
科学领域:
- 关键护理医学 关键护理医学
- 心血管外科心血管外科
背景情况:
- 身体外膜氧化 (ECMO) 是严重呼吸和心力衰竭的救生疗法.
- 为扩大ECMO的可访问性和安全性,开发专门的,专家主导的道化程序至关重要.
研究的目的:
- 详细介绍专业专家领导的ECMO导管计划的培训和认证框架.
- 为了评估由重症医生进行的ECMO管道治疗所产生的并发症率.
主要方法:
- 对该计划的认证流程进行叙事审查.
- 在四年内 (2018年8月至2022年8月) 进行ECMO注射管并发症的回顾分析.
- 按临床意义 (低,中,高) 分类14个预定义的不良事件.
主要成果:
- 在179名患者中进行了402次穿,包括各种ECMO配置和心胸手术.
- 炮射成功率为98.5% (394/400次成功尝试).
- 整体并发症发生率为7.96% (32/402),其中1.7%是具有高临床意义的并发症.
结论:
- 专家领导的ECMO计划的培训和管技术产生了较低的并发症概况.
- 该计划提供复杂的ECMO治疗,并发症率与已发表的文献相美.
- 该模型支持密集医师安全有效地提供ECMO.
相关概念视频
Acute Respiratory Failure-II
218
Type I Respiratory Failure, or hypoxemic respiratory failure, occurs when the partial pressure of oxygen (PaO2) in arterial blood falls below 60 mmHg while breathing room air without a corresponding increase in arterial carbon dioxide levels (PaCO2). This condition highlights a significant impairment in the lungs' capacity to oxygenate the blood.
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
The underlying physiological abnormalities that contribute to hypoxemic respiratory failure include:
218
Mechanical Ventilation II: Invasive Ventilation
131
Ventilators are essential medical equipment used to aid patients with respiratory difficulties. Their primary function is to assist or replace spontaneous breathing by providing mechanical ventilation. There are two general classes of mechanical ventilators: negative-pressure and positive-pressure ventilators.
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
Negative-Pressure Ventilators
Negative-pressure ventilators create a vacuum around the chest or body to draw air into the lungs, simulating breathing. This method does not require an...
131
Acute Respiratory Failure-IV
154
Respiratory failure can manifest suddenly or gradually, characterized by a rapid decline in PaO2 and a rapid rise in PaCO2. This situation indicates a severe respiratory problem that may quickly become a life-threatening emergency. One of the early signs of hypoxemic Acute Respiratory Failure (ARF) is a change in mental status due to the brain's sensitivity to oxygen levels and changes in acid-base balance. Symptoms such as restlessness, confusion, and agitation suggest inadequate oxygen...
154
Acute Respiratory Failure-V
136
The treatment for acute respiratory failure varies based on factors like the underlying cause, overall health, and severity. A collaborative healthcare team is essential for early detection, often through arterial blood gas analysis. Identifying the cause is the primary goal, with treatment strategies adjusted for ventilation/perfusion (V/Q) mismatch, shunting, or diffusion impairment.
Ensure that patients are monitored continuously for their response to therapy, including changes in...
Ensure that patients are monitored continuously for their response to therapy, including changes in...
136
Acute Respiratory Failure-I
204
Acute respiratory failure is a condition characterized by the inability of the lungs to perform their primary function: gas exchange. This failure leads to insufficient oxygen levels (hypoxemia) in the blood, elevated carbon dioxide levels (hypercapnia), or both, causing critical impairment in organ function.
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
Definition: It is defined by specific criteria based on blood gas measurements. Hypoxemia happens when the partial pressure of oxygen (PaO2) falls below 60 mmHg. At the same time,...
204
Acute Respiratory Failure-III
184
Hypercapnic respiratory failure, also known as Type 2 or ventilatory respiratory failure, is a severe condition characterized by the body's inability to effectively remove carbon dioxide (CO2) from the bloodstream. It leads to an arterial CO2 pressure (PaCO2) exceeding 45 mmHg and a blood pH above 7.35. This situation indicates that the body's ventilatory demand, or the ventilation needed to maintain normal PaCO2 levels, surpasses its supply or the maximum gas flow achievable without...
184


